How Mass Spectrometry Is Transforming Neuroendocrine Cancer Research

Curious how mass spectrometry is opening new frontiers in cancer research? In this short clip from my interview with Dr. Rachael Guenter, she shares how mass spec has become an essential tool in her neuroendocrine cancer studies—from uncovering the mechanisms driving tumor suppressors, to profiling protein expression in CRISPR-modified tumor models.

Her team’s cutting-edge work highlights both the big wins and the unique challenges of analyzing rare cancers, plus a preview of exciting findings soon to be published.

#MassSpec #CancerResearch #NeuroendocrineTumors #TranslationalScience #ChromatographyPodcast